Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Affordability improvements may expand coverage: Frdric Leblanc, a pharmacist at iA Financial, notes that insurers are "preparing for everything we need to do so that everybody benefits from a lower price, both in diabetes and eventually in weight management." Sandoz CEO Richard Saynor has described Canada as the world's second-largest GLP-1 market
Deng J, Gu S, Shao H, Dong H, Zou D, Shi L
Originally developed by Eli Lilly as a next-generation obesity treatment, Retatrutide has captured attention from addiction researchers who noticed something remarkable in early trial participants: many spontaneously reported diminished interest in alcohol without any specific intervention targeting drinking behaviour
This observed effect appeared comparable to that observed in a control group of obese patients without MC4R variants, with the weight loss predominantly attributed to fat mass and minimal impact noted on lean body mass
US$ 26.84
US$ 26.42
US$ 21.00
US$ 24.09
US$ 21.97
US$ 27.01
